01 1Centaur Pharmaceuticals
01 1LOXAPINE SUCCINATE USP
01 1India
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2019-05-14
Pay. Date : 2019-05-03
DMF Number : 29977
Submission : 2015-11-06
Status : Active
Type : II
20
Centaur Pharmaceuticals Private Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is LOXAPINE SUCCINATE USP, with a corresponding US DMF Number 29977.
Remarkably, this DMF maintains an Active status since its submission on November 06, 2015, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of May 14, 2019, and payment made on May 03, 2019, indicating their dedication to facilitating drug approvals, Categorized as Type II
